Jim Cramer’s Game Plan: 15 Stocks to Watch

4. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 98

Discussing drug stocks, Cramer mentioned Johnson & Johnson (NYSE:JNJ) and discussed:

“The drug stocks have been having a huge conundrum, right? I mean they have danced to the tune of a new FDA, which falls under the purview of a different kind of guy, RFK Jr. at Health and Human Services. He’s not exactly pharma-friendly. Meanwhile, they’re supposed to be manufacturing all their drugs here or else they’ll be hit with big tariffs.

Vaccines are no-nos, at least allegedly. Monkeys are not to be used for testing anymore. It should be used, AI should be used. And in the case of Johnson & Johnson, reports Tuesday morning, we get an update on the firm’s legal strategy against those suing the company for cancer that was allegedly caused by J&J’s baby talc powder. This stock has been stuck in a range forever. It’s a wild one, but at least it’s not in a perpetual downturn like some of the other pharma companies. I think it could reverse course and break out as long as we get some big news on any new drug. And by the way, it has a lot of great drug franchises, more than almost every other one.”

Johnson & Johnson (NYSE:JNJ) is a healthcare company engaged in researching, developing, manufacturing, and marketing a broad range of medical products.